Search for a command to run...
Guardant Health, Inc.
Diagnostics & Research
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Sep 28, 2026 | Jonathan JacksonD | Stock | Buy |
| $15,001 - $50,000 |
| $177.33 |
| $182.59 |
| +3.0% |
| +2.1% |
Guardant Health COSMOS Study Published in Cancer Research Communications Validates Utility of Guardant Reveal™ Liquid Biopsy Test for Predicting Recurrence in Melanoma
Guardant Health Announces Results From Its COSMOS-MEL01 Trial Shows 81% Sensitivity For Distant Recurrence, 100% Post-Treatment Facility
3 Cash-Burning Stocks with Questionable Fundamentals
These IBD 50 Stocks Are Stalled. That Could Be A Good Thing.
Guggenheim Maintains Buy on Guardant Health, Raises Price Target to $200